← Back to Search

Digital Storytelling for Diabetes (S4C Trial)

N/A
Waitlist Available
Led By Mark L Wieland
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

S4C Trial Summary

This trial aims to assess the efficacy of a digital storytelling intervention, created through a community-based participatory research (CBPR) approach, on self-management of type 2 diabetes mellitus (T2D) among Hispanic adults.

Who is the study for?
This trial is for Hispanic adults aged 18-70 with type 2 diabetes, who have had an A1c level of at least 8%, and have been diagnosed for six months or more. Participants must receive care at the clinic site, plan to continue there for the next six months, and cannot join if a household member is already in the study.Check my eligibility
What is being tested?
The trial tests a digital storytelling intervention aimed at improving diabetes self-management among Hispanic adults. It uses personal stories captured through community-based participatory research to motivate behavioral change via videos.See study design
What are the potential side effects?
Since this intervention involves digital storytelling without medical or drug treatments, traditional physical side effects are not expected. However, emotional impacts due to relatable stories may occur.

S4C Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glycemic control as measured by hemoglobin A1c. Hemoglobin A1c will be measured from whole blood samples obtained and analyzed in a blinded fashion.
Secondary outcome measures
Body mass index
Diabetes self-management behaviors will be assessed with the Summary of Diabetes Self-Care Activities Measure (SDSCA).
Seated blood pressure measurements (systolic and diastolic) will be made on the right arm using an automated blood pressure device after sitting quietly for five minutes.
+1 more

S4C Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The intervention group will view the 12-minute digital storytelling intervention that has been previously pilot-tested, in addition to usual clinical care.
Group II: ControlActive Control1 Intervention
The comparison group will receive usual clinical care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Digital Storytelling Intervention
2019
N/A
~560

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,206 Previous Clinical Trials
3,766,633 Total Patients Enrolled
Hennepin Healthcare, Minneapolis, MNUNKNOWN
Mountain Park Health Center - Phoenix, AZUNKNOWN

Media Library

Digital Storytelling Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03766438 — N/A
Type 2 Diabetes Research Study Groups: Intervention, Control
Type 2 Diabetes Clinical Trial 2023: Digital Storytelling Intervention Highlights & Side Effects. Trial Name: NCT03766438 — N/A
Digital Storytelling Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03766438 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor welcoming individuals aged 50 and up?

"To qualify for this trial, prospective participants must fall within the age window of 18-70. For those younger than 18 and older than 65 there are 184 studies available, as well as 897 additional trials."

Answered by AI

What type of participants would be most advantageous for this medical experiment?

"This clinical trial is in need of 450 volunteers, aged between 18 and 70 years old, who are diagnosed with type 2 diabetes. Additionally, these prospective participants must have visited the primary care site within the last year; self-identify as Hispanic or Latino; intend to remain at the clinic for a total of 6 months; confirm their diagnosis has been present for more than half a year and show an A1c level exceeding 8%. Lastly, individuals residing in the same household as another registered volunteer cannot participate."

Answered by AI

Are there any vacancies remaining for participants in this experiment?

"The clinicaltrials.gov listing shows that this trial, which was first posted on February 14th 2019 and last modified April 6th 2022, is currently not enrolling participants. However, there are 1195 other trials actively recruiting at the present time."

Answered by AI

Who else is applying?

What state do they live in?
Arizona
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

~73 spots leftby Apr 2025